COVID-19及结直肠癌筛查暂停对荷兰结直肠癌发病率和分期分布的影响
本研究基于荷兰癌症登记数据,分析COVID-19第一波期间及之后55-75岁人群在25家医院的结直肠癌发病与分期分布。2020年4-6月总发病率下降最大,其中48%归因于I期,23%归因于II期,23%归因于III期,5%归因于IV期。2020年5月中旬逐步恢复筛查后,7月起诊断数增加,至2020年10月观察诊断数高于预期。
要点
- 2020年4-6月结直肠癌总发病率下降最大,其中48%归因于I期。
- 2020年5月中旬逐步恢复筛查后,7月起诊断数增加,10月观察数高于预期。
- 下降主要限于I期结直肠癌,对分期分布和死亡率的长期影响似乎最小。
核心结论
- 由于下降主要限于I期结直肠癌,COVID-19大流行导致筛查计划暂停似乎对分期分布和结直肠癌死亡率的长期影响最小。
研究设计与样本
- 研究从荷兰癌症登记处提取2020年3月至12月期间25家医院55-75岁人群的结直肠癌发病和分期数据。
- 将暂停筛查后(2020年3月至2020年12月)的观察发病率与同期预期发病率进行比较。
主要发现
- 2020年4月至6月观察到结直肠癌总发病率下降最大。
- 总发病率下降中48%归因于I期,23%归因于II期,23%归因于III期,5%归因于IV期。
- 2020年5月中旬逐步恢复筛查后,从2020年7月起结直肠癌诊断数增加。
- 截至2020年10月,观察诊断数高于预期数。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Many countries had to suspend their colorectal cancer (CRC) screening programme as a result of the COVID-19 pandemic. This eventually may lead to postponed diagnoses of premalignant lesions and CRC, resulting in increased incidence or more advanced CRCs rates. This study aimed to assess the impact of the COVID-19 pandemic on incidence and stage distribution of CRCs in the Netherlands, by monitoring CRC diagnoses and stage distribution in the months before, during and after the first COVID-19 wave. Data on incidence and stage distribution of CRCs of individuals aged 55-75 years in 25 hospitals in the Netherlands were extracted from the Netherlands Cancer Registry. The observed incidence after the suspension (March 2020-December 2020) was compared to the expected incidence in the same period. In the period April to June 2020, we observed the largest decrease in the total incidence of CRC. We found that 48% of the decrease was due to stage I, 23% due to stage II, 23% due to stage III and 5% due to stage IV. After gradually resuming screening mid May 2020, we observed an increase in CRC diagnoses from July 2020 onwards. As of October 2020, the observed number of diagnoses was higher than the expected number. As the decrease was mainly limited to stage I CRCs, it seems that the temporary suspension of the CRC screening programme due to the COVID-19 pandemic will have a minimal long-term impact on stage distribution and CRC mortality.
引用
- Toes-Zoutendijk E, Vink G, Nagtegaal ID, et al. Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands. Eur J Cancer. 2021. PMID: 34915408. doi:10.1016/j.ejca.2021.11.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。